PMVP (PMV Pharmaceuticals Inc.) Earnings per share for the last four quarters

Public company logo of PMV Pharmaceuticals Inc. (PMVP)

PMV Pharmaceuticals develops innovative agents for p53 protein restoration in the US. The model's viability relies on clinical trial outcomes and strict cash monitoring. The team consists of highly qualified biologists attracted by generous bonuses and state-of-the-art equipment. Serving as an evaluation tool, this EPS (TTM) chart shows a value of 3.10, visualizing the financial dynamics of the company.

PMVP pmvpharma.com Earnings per share for the last twelve months (02/11/2024 - 11/17/2026)

PMV Pharmaceuticals Inc. - analytical breakdowns and key metrics (PMVP)

- current price and projected stock value:
- business market valuation indicators:
Fundamental valuation:PMV Pharmaceuticals, Inc. (PMVP)
Signature product of PMV Pharmaceuticals, Inc.

The twelve-month earnings per share trend reflects the pace of net income capitalization, determining market value through the discounting of future cash flows. For PMV Pharmaceuticals (PMVP), the 12-month YoY percentage change in EPS serves as an indicator of cost efficiency in developing p53 mutation therapies and the precision of patient selection for the drug PC14586, signaling the business's ability to scale the value of its clinical trials.

Competitor analysis for PMV Pharmaceuticals

Earnings per share for the trailing year GMAB (Genmab US)|EXEL (Exelixis) - Net earnings per share for the last 12 months|NUVL: Earnings per share for the last four quarters|KYMR (Kymera Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ideayabio.com|Earnings per share for the last twelve months Enliven Therapeutics, Inc. (ELVN)|ORIC (ORIC Pharmaceuticals, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) RLAY (Relay Therapeutics Inc)|Net earnings per share for the trailing year Nurix Pharma|Tyra Biosciences Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Verastem|GLUE (Monte Rosa Therapeutics) - Net earnings per share for the last 12 months|CGEM: Earnings per share for the last four quarters|IMRX (immuneering.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months C4 Tx CCCC|Net earnings per share (EPS TTM) BDTX|Repare Therapeutics Inc. - Earnings per share for the last 12 months|Karyopharm Therapeutics - Net earnings per share for the last 12 months|Earnings per share for the trailing year PPCB|BGMS: Net earnings per share for the last 12 months|aadibio.com - Earnings per share for the last four quarters|ALRN: Net earnings per share (EPS TTM)|Blueprint Medicines Corp. - Earnings per share for the trailing year|GLYC (GlycoMimetics Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months SpringWorks Therapeutics Inc. SWTX